Your browser doesn't support javascript.
loading
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
Kedor, Claudia; Listing, Joachim; Zernicke, Jan; Weiß, Anja; Behrens, Frank; Blank, Norbert; Henes, Joerg Christoph; Kekow, Joern; Rubbert-Roth, Andrea; Schulze-Koops, Hendrik; Seipelt, Eva; Specker, Christof; Feist, Eugen.
Afiliação
  • Kedor C; Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany claudia.kedor@charite.de.
  • Listing J; Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.
  • Zernicke J; Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Weiß A; Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.
  • Behrens F; CIRI/Rheumatology and Fraunhofer TMP, Goethe-University, Frankfurt, Germany.
  • Blank N; Internal Medicine 5, University of Heidelberg, Heidelberg, Germany.
  • Henes JC; Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Oncology, Haematology, Immunology, Rheumatology, Pulmology), University Hospital Tuebingen, Tuebingen, Germany.
  • Kekow J; Clinic of Rheumatology and Orthopaedics, Otto-von-Guericke University Magdeburg, Vogelsang-Gommern, Germany.
  • Rubbert-Roth A; Division of Rheumatology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
  • Schulze-Koops H; Department of Rheumatology, University of Munich, Munich, Germany.
  • Seipelt E; Abteilung Rheumatologie und Klinische Immunologie, Immanuel Krankenhaus Berlin, Standort Berlin-Buch, Berlin, Germany.
  • Specker C; Klinik für Rheumatologie und Klinische Immunologie, KEM Kliniken Essen-Mitte, Essen, Germany.
  • Feist E; Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Ann Rheum Dis ; 79(8): 1090-1097, 2020 08.
Article em En | MEDLINE | ID: mdl-32404342
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Still de Início Tardio / Antirreumáticos / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Still de Início Tardio / Antirreumáticos / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha